5-Amino-1MQ is soluble in sterile water, saline, or bacteriostatic water
Pivotal trial result: AOD-9604's Phase 2b trial (536 subjects, 24 weeks) failed its primary endpoint
This can occur due to loss of appetite, digestive issues, and muscle weakness, which are common side effects of B12 deficiency
Research suggests it encourages the breakdown of stored fat without significantly affecting blood sugar or acting through the IGF-1 pathway
For more detailed assessment, periodic blood work including metabolic panels, lipid profiles, and inflammatory markers can provide objective data on how the compound affects health parameters
The timeline for results can vary depending on the individual and the specific peptides being used